These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2856354)

  • 1. [Treatment of venous thromboembolic disease using low molecular weight CY216 heparin in patients with high risk of hemorrhage].
    Prandoni P; Vigo M; Tropeano PF; Carletti E; Corbetti F; Antonello G; Cuppini S
    Ann Ital Med Int; 1988; 3(3):213-9. PubMed ID: 2856354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 4. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical potential of low molecular weight heparins.
    Messmore HL
    Semin Thromb Hemost; 1989 Oct; 15(4):405-8. PubMed ID: 2554501
    [No Abstract]   [Full Text] [Related]  

  • 6. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism.
    Hirsh J; Siragusa S; Cosmi B; Ginsberg JS
    Thromb Haemost; 1995 Jul; 74(1):360-3. PubMed ID: 8578485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant treatment in deep venous thrombosis].
    Navarro JL
    Sangre (Barc); 1993 Apr; 38(2):125-30. PubMed ID: 8390725
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a patient with an undefined hypercoagulable state with long-term low-molecular-weight heparin.
    Dobie SA; Ellsworth AJ; Linenberger ML
    West J Med; 1996 Apr; 164(4):350-3. PubMed ID: 8732743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heparin-induced hemorrhage in the treatment of venous thromboembolism].
    Monreal M; Casals A; Las Heras G; Roncalés J; Callejas JM; Martorell A; Lisbona C
    Angiologia; 1990; 42(1):11-5. PubMed ID: 2321800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new in the prevention, diagnosis and treatment of venous thromboembolic disease.
    Jones JS
    J Miss State Med Assoc; 1997 Apr; 38(4):115-8. PubMed ID: 9114668
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prevention of thromboembolic disease in medical patients: heparin-calcium or low-molecular-weight heparin?].
    de los Santos-Sastre S
    An Med Interna; 1993 Sep; 10(9):465-6. PubMed ID: 8218806
    [No Abstract]   [Full Text] [Related]  

  • 14. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient treatment of patients with pulmonary embolism.
    Wells PS; Büller HR
    Semin Vasc Med; 2001 Nov; 1(2):229-34. PubMed ID: 15199507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
    Ruiz Manzano J; Monreal M
    Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative dosage and toxicity of heparin sodium in the treatment of patients with pulmonary embolism versus deep-vein thrombosis.
    Tenero DM; Bell HE; Deitz PA; Bertino JS
    Clin Pharm; 1989 Jan; 8(1):40-3. PubMed ID: 2912663
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of thromboses with low-molecular-weight heparins].
    Haas S; Haas P
    Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of venous thromboembolism].
    Niederer A; Wuillemin WA
    Praxis (Bern 1994); 2001 Feb; 90(6):213-9. PubMed ID: 11235642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.